InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Climb Bio, Inc.

CLYM Clue Score37
United States Fiscal year ends December CIK 0001768446 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
40,000
$1.29
$51.60K
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
10,000
$7.89
$78.90K
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
10,000
$3.00
$30.00K
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
10,000
$3.46
$34.60K
Valerie Morisset
1 Jul 2024
EVP, R&D and CSO
Exercised, kept
7,649
$0.00
$1.53
Valerie Morisset
5 Apr 2024
EVP, R&D and CSO
Exercised, kept
17,847
$0.00
$3.57
Valerie Morisset
20 Sep 2023
EVP, R&D and CSO
Exercised, kept
15,297
$0.00
$3.06
Valerie Morisset
20 Sep 2023
EVP, R&D and CSO
Exercised, kept
5,431
$0.00
$10.86
Valerie Morisset
10 Mar 2023
EVP, R&D and CSO
Exercised, kept
61,191
$0.00
$12.24
Valerie Morisset
10 Mar 2023
EVP, R&D and CSO
Exercised, kept
255,219
$0.00
$510.44
Show all 45 transactions →

What was left out

Form 4 filings counted 96
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 37,676,580
History held since 11 Aug 2021